Your browser doesn't support javascript.
loading
Sorafenib pretreatment enhances radiotherapy through targeting MEK/ERK/NF-κB pathway in human hepatocellular carcinoma-bearing mouse model.
Chen, John Chun-Hao; Chuang, Hui-Yen; Hsu, Fei-Ting; Chen, Yi-Chen; Chien, Yi-Chun; Hwang, Jeng-Jong.
Afiliação
  • Chen JC; Department of Biomedical Imaging and Radiological Sciences, National Yang-Ming University, Taipei, Taiwan.
  • Chuang HY; Department of Radiation Oncology, Mackay Memorial Hospital, New Taipei City, Taiwan.
  • Hsu FT; Department of Biomedical Imaging and Radiological Sciences, National Yang-Ming University, Taipei, Taiwan.
  • Chen YC; Department of Biomedical Imaging and Radiological Sciences, National Yang-Ming University, Taipei, Taiwan.
  • Chien YC; Department of Radiology, National Taiwan University Hospital, Taipei, Taiwan.
  • Hwang JJ; Department of Medical Imaging and Radiological Sciences, I-Shou University, Jiaosu Village, Kaohsiung, Taiwan.
Oncotarget ; 7(51): 85450-85463, 2016 Dec 20.
Article em En | MEDLINE | ID: mdl-27863427

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Compostos de Fenilureia / NF-kappa B / Niacinamida / Carcinoma Hepatocelular / MAP Quinase Quinase Quinases / MAP Quinases Reguladas por Sinal Extracelular / Quimiorradioterapia / Neoplasias Hepáticas / Antineoplásicos Tipo de estudo: Prognostic_studies Limite: Animals / Humans / Male Idioma: En Ano de publicação: 2016 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Compostos de Fenilureia / NF-kappa B / Niacinamida / Carcinoma Hepatocelular / MAP Quinase Quinase Quinases / MAP Quinases Reguladas por Sinal Extracelular / Quimiorradioterapia / Neoplasias Hepáticas / Antineoplásicos Tipo de estudo: Prognostic_studies Limite: Animals / Humans / Male Idioma: En Ano de publicação: 2016 Tipo de documento: Article